0001209191-23-007655.txt : 20230207
0001209191-23-007655.hdr.sgml : 20230207
20230207180013
ACCESSION NUMBER: 0001209191-23-007655
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230203
FILED AS OF DATE: 20230207
DATE AS OF CHANGE: 20230207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shameze Rampertab
CENTRAL INDEX KEY: 0001721810
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19437
FILM NUMBER: 23596406
MAIL ADDRESS:
STREET 1: C/O ZOMEDICA PHARMACEUTICALS CORP.
STREET 2: 3928 VARSITY DRIVE
CITY: ANN ARBOR
STATE: MI
ZIP: 48108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ASENSUS SURGICAL, INC.
CENTRAL INDEX KEY: 0000876378
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 112962080
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 TW ALEXANDER DRIVE
STREET 2: SUITE 160
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-765-8400
MAIL ADDRESS:
STREET 1: 1 TW ALEXANDER DRIVE
STREET 2: SUITE 160
CITY: DURHAM
STATE: NC
ZIP: 27703
FORMER COMPANY:
FORMER CONFORMED NAME: TRANSENTERIX, INC.
DATE OF NAME CHANGE: 20190712
FORMER COMPANY:
FORMER CONFORMED NAME: TRANSENTERIX INC.
DATE OF NAME CHANGE: 20131210
FORMER COMPANY:
FORMER CONFORMED NAME: SafeStitch Medical, Inc.
DATE OF NAME CHANGE: 20080211
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-03
0
0000876378
ASENSUS SURGICAL, INC.
ASXC
0001721810
Shameze Rampertab
C/O ASENSUS SURGICAL, INC.
1 TW ALEXANDER DRIVE, SUITE 160
DURHAM
NC
27703
0
1
0
0
EVP, Chief Financial Officer
Common Stock
2023-02-04
4
M
0
248512
0.00
A
342170
D
Common Stock
2023-02-04
4
F
0
103998
0.75
D
238172
D
Stock Options
0.75
2023-02-03
4
A
0
175000
0.00
A
2030-02-03
Common Stock
175000
175000
D
Restricted Stock Units
0.00
2023-02-03
4
A
0
175000
0.00
A
Common Stock
175000
175000
D
Restricted Stock Units
0.00
2023-02-03
4
A
0
350000
0.00
A
Common Stock
350000
350000
D
Restricted Stock Units
0.00
2023-02-04
4
M
0
84270
0.00
D
Common Stock
84270
0
D
Restricted Stock Units
0.00
2023-02-04
4
M
0
19704
0.00
D
Common Stock
19704
19704
D
Restricted Stock Units
0.00
2023-02-04
4
M
0
19704
0.00
D
Common Stock
19704
19704
D
Restricted Stock Units
0.00
2023-02-04
4
M
0
62417
0.00
D
Common Stock
62417
124833
D
Restricted Stock Units
0.00
2023-02-04
4
M
0
62417
0.00
D
Common Stock
62417
124833
D
This transaction represents the payment of a tax liability on the lapse of forfeiture restrictions on a derivative security and acquisition of the underlying shares.
Vests one-third annually on each of February 3, 2024, 2025 and 2026, subject to acceleration as set forth in the Registrant's Amended and Restated Incentive Compensation Plan ("Plan") and the Reporting Person's Employment Agreement with the Registrant ("Employment Agreement").
Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock.
Forfeiture restrictions will lapse on the RSUs in three equal installments on each of February 4, 2024, 2025 and 2026, as long as the Reporting Person remains in continuous service during the vesting period, subject to acceleration as set forth in the Plan and the Employment Agreement.
Each performance-based restricted stock unit ("PRSU") represents the right to receive one share of the Registrant's common stock.
PRSU award with time-based vesting in three equal installments on each of February 4, 2024, 2025 and 2026, and performance-based vesting only if designated corporate goals are met.
Lapse of forfeiture restrictions on discretionary bonus RSUs.
Lapse of forfeiture on second one-third of an award of RSUs from this grant made on February 8, 2021. Forfeiture restrictions will lapse on the remaining RSUs on February 4, 2024, as long as the Reporting Person remains in continuous service during the vesting period, subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement.
Lapse of forfeiture restrictions on second one-third of a PRSU award granted on February 8, 2021, upon the achievement of time and performance goals. Forfeiture restrictions will lapse on the remaining PRSUs on February 4, 2024, as long as the Reporting Person provides continuous service during the vesting period, subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement.
Lapse of forfeiture restrictions on one-third of a RSU award granted on February 4, 2022. Forfeiture restrictions will lapse on the remaining RSUs on February 4, 2024 and 2025, as long as the Reporting Person provides continuous service to the Company during the vesting period and subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement.
Lapse of forfeiture restrictions on one-third of a PRSU award granted on February 4, 2022 upon the achievement of time and performance goals. Forfeiture restrictions will lapse on the remaining PRSUs on each of February 4, 2024 and 2025, subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement.
/s/ Joshua Weingard, as attorney-in-fact for Shameze Rampertab
2023-02-07